RxDoctor Payments Data

Thomas Nohe

Physician Assistant · Blanco, TXNPI 1295964591

Payments from drug & device makers

$7,814in general payments, 2019–2025

Across 268 payments — averaging $29.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$1K
  • AbbVie$752
  • Lilly USA, LLC$472
  • Takeda Pharmaceuticals U.S.A., Inc.$398
  • Pfizer$370
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$7,814100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,814 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$43,024
FarxigaDapagliflozin Propanediol32$32,821
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$27,566
MounjaroTirzepatide13$19,417
TrulicityDulaglutide14$19,360
EliquisApixaban17$15,334
JardianceEmpagliflozin12$11,356
SynthroidLevothyroxine Sodium29$2,212
Albuterol Sulfate HfaAlbuterol Sulfate49$1,675
Rosuvastatin Calcium90$1,017
Levothyroxine Sodium67$971
Boostrix TdapDiphth,pertuss(Acell),tet Vac13$922
Atorvastatin Calcium98$920
Losartan Potassium75$896
ValacyclovirValacyclovir Hcl18$716

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,027$43,02425 claims
Lilly USA, LLCMounjaro, Trulicity$472$38,77727 claims
AstraZenecaFarxiga$2,292$32,82132 claims
GSKTrelegy Ellipta$208$27,56645 claims
PfizerEliquis$370$15,33417 claims
Boehringer IngelheimJardiance$76$11,35612 claims
AbbVieSynthroid$752$2,21229 claims
Almatica Pharma LLCSertraline Hcl$17$27224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Blanco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →